Pages that link to "Q30453929"

The following pages link to Oxytocin in schizophrenia: a review of evidence for its therapeutic effects (Q30453929):

Displaying 40 items.

• Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis (Q26749390) (← links)
• Oxytocin and Vasopressin Receptor Gene Polymorphisms: Role in Social and Psychiatric Traits (Q26768063) (← links)
• From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders (Q26770469) (← links)
• Research review: Social motivation and oxytocin in autism--implications for joint attention development and intervention (Q26824603) (← links)
• The relationship between central and peripheral oxytocin concentrations: a systematic review and meta-analysis protocol (Q28066450) (← links)
• The Neurobiological Basis for Social Affiliation in Autism Spectrum Disorder and Schizophrenia. (Q30355076) (← links)
• Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment. (Q30372084) (← links)
• Current and emergent treatments for symptoms and neurocognitive impairment in schizophrenia. (Q30382281) (← links)
• A Role for Oxytocin in the Etiology and Treatment of Schizophrenia (Q30408983) (← links)
• Oxytocin reduces amygdala activity, increases social interactions, and reduces anxiety-like behavior irrespective of NMDAR antagonism (Q30659389) (← links)
• Potential of Oxytocin in the Treatment of Schizophrenia (Q33761384) (← links)
• The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings (Q33994774) (← links)
• Association between oxytocin receptor gene polymorphisms and self-rated 'empathic concern' in schizophrenia (Q34532471) (← links)
• Associations between oxytocin receptor genotypes and social cognitive performance in individuals with schizophrenia (Q34624043) (← links)
• Oxytocin and social cognition in affective and psychotic disorders (Q35646296) (← links)
• Increased Serum Levels of Oxytocin in 'Treatment Resistant Depression in Adolescents (TRDIA)' Group (Q36106577) (← links)
• Oxytocin system dysfunction as a common mechanism underlying metabolic syndrome and psychiatric symptoms in schizophrenia and bipolar disorders (Q36238675) (← links)
• Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders (Q36685572) (← links)
• Characterization of the effects of oxytocin on fear recognition in patients with schizophrenia and in healthy controls (Q37022856) (← links)
• Oxytocin's effect on resting-state functional connectivity varies by age and sex (Q37088090) (← links)
• Oxytocin and socioemotional aging: Current knowledge and future trends (Q37126568) (← links)
• A meta-analysis and theoretical critique of oxytocin and psychosis: prospects for attachment and compassion in promoting recovery (Q38192728) (← links)
• Development of novel therapy of schizophrenia in children and adolescents. (Q38223714) (← links)
• Social neuroscience in psychiatry: unravelling the neural mechanisms of social dysfunction. (Q38261819) (← links)
• Oxytocin, testosterone, and human social cognition (Q38336027) (← links)
• A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia (Q38593718) (← links)
• The neurobiology of mammalian parenting and the biosocial context of human caregiving (Q38603574) (← links)
• On the role of oxytocin in borderline personality disorder (Q38652239) (← links)
• Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis (Q38674187) (← links)
• Oxytocin and Social Cognitions in Schizophrenia: A Systematic Review (Q38675134) (← links)
• Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward (Q38683538) (← links)
• Apathy in Dementia: Systematic Review of Recent Evidence on Pharmacological Treatments (Q38977500) (← links)
• Interactions of vasopressin and oxytocin receptors with vasopressin analogues substituted in position 2 with 3,3'-diphenylalanine--a molecular docking study. (Q43438262) (← links)
• Oxytocin and MDMA ('Ecstasy') enhance social reward in rats (Q47731855) (← links)
• Oxytocin and vasopressin levels are decreased in the plasma of male schizophrenia patients (Q50303936) (← links)
• Testing synaptic plasticity in dynamic mate choice decisions: N-methyl D-aspartate receptor blockade disrupts female preference (Q51141409) (← links)
• Oxytocin bei Schizophrenie (Q60619756) (← links)
• Endogenous oxytocin response to film scenes of attachment and loss is pronounced in schizophrenia (Q60937279) (← links)
• Acoustic prepulse inhibition in male and female prairie voles: Implications for models of neuropsychiatric illness (Q90505279) (← links)
• Can the new epidemiology of schizophrenia help elucidate its causation? (Q91318349) (← links)